U.S. Clinical Perinatal Software Market Size, Share & Forecast 2026–2032
Report Highlights
- ✓Country: United States
- ✓Market: Clinical Perinatal Software Market
- ✓Market Size 2024: USD 1.42 billion
- ✓Market Size 2032: USD 2.61 billion
- ✓CAGR: 7.9%
- ✓Base Year: 2025
- ✓Forecast Period: 2026–2032
Analyst Recommendation — Demand Certified FHIR APIs: Buyers should require certified FHIR R4 APIs in every obstetric module contract signed during 2025 and 2026, since CMS-0057-F enforces API compliance from January 1, 2027. Vendors unable to certify by that date should be excluded from shortlists.
Clinical Perinatal Software in the U.S.: Market Overview
The U.S. clinical perinatal software market was valued at USD 1.42 billion in 2024 and is forecast to reach USD 2.61 billion by 2032. It spans electronic fetal monitoring analytics, labor and delivery documentation, neonatal intensive care informatics, and postpartum risk scoring. Market structure is split between large EHR vendors such as Epic Systems and Oracle Health, which bundle obstetric modules, and device-software firms such as GE HealthCare and Philips, which sell monitoring analytics alongside hardware.
Policy has shaped the market's form more than private demand has. The HITECH Act of 2009 and the CMS Medicare and Medicaid EHR Incentive Programs, now administered as Promoting Interoperability, forced hospitals to adopt certified EHRs, creating the documentation backbone that obstetric modules now extend. Private firms led in fetal monitoring analytics and decision support, where Natus Medical and Mindray competed on algorithms long before federal reimbursement recognized them.
Policy-Driven Growth in U.S. Perinatal Software
The American Rescue Plan Act of 2021, Section 9812, gave states the option to extend Medicaid postpartum coverage from 60 days to 12 months, and Medicaid finances roughly 41 percent of U.S. births. Longer coverage extends the billable window for remote blood pressure monitoring and postpartum risk-scoring software, allowing vendors to bill recurring subscriptions rather than one-time implementations. The CMS Transforming Maternal Health (TMaH) Model, launched in January 2024, channels funding to selected state participants to deploy maternal care technology, converting coverage policy into procurement budgets.
The Preventing Maternal Deaths Act of 2018 (Public Law 115-344) reauthorized state maternal mortality review committees and encouraged structured severe maternal morbidity data capture, pushing hospitals to add standardized obstetric fields to EHR workflows. The ONC HTI-1 Final Rule, published December 2023, requires certified health IT developers to disclose source attributes for predictive decision support interventions under 45 CFR Part 170, with compliance phased in from January 1, 2025. This transparency mandate rewards vendors with certified obstetric risk-scoring tools, because hospital buyers now demand documented provenance before deployment.
Regulatory Barriers and Compliance Costs for U.S. Perinatal Software
FDA's Center for Devices and Radiological Health regulates perinatal software that analyzes fetal heart rate or predicts obstetric deterioration as a medical device under the Federal Food, Drug, and Cosmetic Act. Most such products require 510(k) clearance, and the MDUFA V performance goal sets a 90 FDA-day review target, but elapsed time including deficiency responses typically extends to six to twelve months. The Quality Management System Regulation under 21 CFR Part 820, aligned with ISO 13485:2016, takes effect February 2, 2026, requiring vendors to re-document design controls and supplier management before that date.
The HHS Office of the National Coordinator, now within the Assistant Secretary for Technology Policy, enforces information blocking provisions created by Section 4004 of the 21st Century Cures Act. Developers face civil monetary penalties of up to USD 1 million per violation, and an interface that restricts clinicians' access to a patient's labor record can trigger enforcement. Vendors must also meet ONC Health IT certification criteria under 45 CFR Part 170 and HIPAA Security Rule requirements administered by the HHS Office for Civil Rights, adding audit and encryption costs to every hospital deployment.
Opportunities Created by Policy in U.S. Perinatal Software
The TMaH Model creates a procurement pathway for state-funded maternal software, particularly remote patient monitoring tools billed under CPT codes 99453, 99454, and 99457 for device setup, data transmission, and clinical management. Vendors that package these codes with postpartum hypertension alerts gain reimbursable value inside Medicaid managed care contracts. Opportunity concentrates in states that have adopted the 12-month postpartum extension, because those programs supply the continuous coverage needed to support subscription pricing.
CMS-0057-F, the Interoperability and Prior Authorization Final Rule, requires impacted payers to implement HL7 FHIR APIs from January 1, 2027, opening demand for FHIR-native obstetric modules that exchange data with payer systems. HTI-1 transparency requirements create a second opening, since hospitals procuring predictive labor-risk tools need certified products with documented training data. Vendors that package these attributes into certified modules capture share from non-certified competitors that cannot clear hospital governance reviews.
Market at a Glance
| Metric | Value |
|---|---|
| Market Size 2024 | USD 1.42 billion |
| Market Size 2032 | USD 2.61 billion |
| Growth Rate (CAGR) | 7.9% |
| Most Critical Decision Factor | FDA clearance and FHIR interoperability compliance readiness |
| Largest Region | South Census Region |
| Competitive Structure | Concentrated among EHR platforms and device incumbents, with fragmented specialist vendors |
Leading Market Participants
- GE HealthCare
- Philips
- Epic Systems
- Oracle Health
- Natus Medical
- Mindray
- Hologic
- Masimo
- Medtronic
- Dräger
Regulatory and Policy Environment for U.S. Perinatal Software
The primary legislation is the Federal Food, Drug, and Cosmetic Act, with software functions governed by FDA guidance including Clinical Decision Support Software (September 2022) and final guidance on Predetermined Change Control Plans for AI-enabled device software functions (December 2024). Interoperability and information blocking fall under Section 4004 of the 21st Century Cures Act, implemented through 45 CFR Parts 170 and 171. Key compliance requirements include FDA 510(k) clearance, QMSR conformance from February 2, 2026, certified FHIR APIs under CMS-0057-F from January 1, 2027, and HIPAA Security Rule compliance, administered by FDA CDRH, ASTP/ONC, CMS, and HHS OCR.
Compared with regional peers, the U.S. relies on a product-based premarket clearance route, whereas the EU Medical Device Regulation (EU) 2017/745 classifies standalone software under Rule 11 and requires notified body certification. The EU Artificial Intelligence Act, Regulation (EU) 2024/1689, imposes high-risk obligations on medical AI from August 2027, a deadline without an equivalent U.S. statutory counterpart. Health Canada applies a risk-based licensing regime for software as a medical device, which is less prescriptive on interoperability than CMS-0057-F.
Long-Term Policy Outlook for U.S. Perinatal Software
By 2032, the policy environment will tighten around AI-enabled obstetric tools, with FDA extending PCCP-based oversight to adaptive algorithms used in labor monitoring and postpartum risk scoring. Congress is expected to decide whether the Medicaid 12-month postpartum option becomes a permanent national standard, a decision that would lift subscription revenue across all states. Continued CMS funding for TMaH-style state models will sustain procurement demand through the forecast period.
These changes will reshape the market toward platform consolidation, as EHR vendors such as Epic Systems and Oracle Health absorb standalone obstetric analytics through certified APIs. Standalone fetal monitoring vendors lacking FHIR-native architecture and PCCP documentation will lose hospital contracts to bundled offerings. Reimbursement pressure from CMS remote monitoring codes will make per-patient analytics pricing the dominant commercial model by 2032.
Frequently Asked Questions
Market Segmentation
- Cloud-Based
- On-Premise
- Hybrid
- Software as a Service
- Fetal Monitoring Analytics
- Labor and Delivery Documentation
- Neonatal Care Informatics
- Postpartum Risk Monitoring
- Hospitals
- Ambulatory Birth Centers
- Maternity Clinics
- Medicaid Managed Care Plans
Table of Contents
Research Framework and Methodological Approach
Information
Procurement
Information
Analysis
Market Formulation
& Validation
Overview of Our Research Process
MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.
1. Data Acquisition Strategy
Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.
- Company annual reports & SEC filings
- Industry association publications
- Technical journals & white papers
- Government databases (World Bank, OECD)
- Paid commercial databases
- KOL Interviews (CEOs, Marketing Heads)
- Surveys with industry participants
- Distributor & supplier discussions
- End-user feedback loops
- Questionnaires for gap analysis
Analytical Modeling and Insight Development
After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.
2. Market Estimation Techniques
MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.
Bottom-up Approach
Aggregating granular demand data from country level to derive global figures.
Top-down Approach
Breaking down the parent industry market to identify the target serviceable market.
Supply Chain Anchored Forecasting
MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.
Supply-Side Evaluation
Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.
3. Market Engineering & Validation
Market engineering involves the triangulation of data from multiple sources to minimize errors.
Extensive gathering of raw data.
Statistical regression & trend analysis.
Cross-verification with experts.
Publication of market study.
Client-Centric Research Delivery
MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.